In anti-Ro/SSA antibody-positive patients, the modulation of ion channel function by inflammatory cytokines and the promotion of myocardial fibrosis might further and significantly increase the risk of arrhythmias. The gene discussed is TRIM21; the disease is cardiac arrhythmia.